What Blood Test Abnormalities Are Common in FIP

Feline Infectious Peritonitis (FIP) remains one of the most complex and devastating diseases affecting cats worldwide. Its elusive clinical presentation and the difficulty of definitive diagnosis challenge veterinarians daily. Blood tests provide vital clues, helping guide suspicion and treatment. This article investigates the landscape of commonly observed blood test abnormalities in FIP, unpacks their underlying mechanisms, and discusses their diagnostic relevance within American veterinary practice.

Feline Infectious Peritonitis, caused by a mutation in feline coronavirus, brings forth a range of systemic manifestations. While direct tests for FIP are either unavailable or unreliable, thorough bloodwork frequently points to the disease. Understanding these laboratory markers is essential for prompt recognition, supportive care, and differential diagnosis.

Complete Blood Count (CBC) Changes

CBC profiles in FIP frequently demonstrate several hallmark findings. The most consistent abnormality is a persistent, often nonregenerative anemia. The red blood cell count may be moderately to severely reduced. This is typically classified as a normocytic, normochromic anemia, resulting from chronic inflammation rather than blood loss or destruction.

Leukocyte patterns vary depending on the stage and form of FIP. In many cases, moderate to marked leukocytosis is observed, dominated by increased neutrophil counts (neutrophilia). This elevation reflects the robust inflammatory activity associated with FIP. Occasional neutropenia may be seen, especially in advanced or acute cases where overwhelming infection suppresses marrow function. Mild monocytosis is another frequent finding, underlining the chronicity of immune system activation.

Lymphocyte populations often decrease—lymphopenia is common. This is partially attributed to viral-induced immunosuppression, making affected cats more vulnerable to secondary infections. Platelet numbers, in contrast, generally remain within normal limits. Thrombocytopenia is not a defining characteristic of FIP but may arise occasionally due to concurrent complications.

Serum Biochemistry Profile

Biochemistry panels are invaluable for highlighting organ involvement and systemic inflammation. One of the most notable and consistent findings in cats suffering from FIP is elevated total serum protein, mainly hyperglobulinemia. This rise stems from excessive antibody production and chronic inflammatory stimulation. Albumin, conversely, frequently drops, leading to a decreased albumin-to-globulin (A:G) ratio—values below 0.4 are strongly suggestive of FIP in many cases.

The globulin fraction, specifically gamma globulins, becomes pronouncedly high. This reflects both polyclonal gammopathy and the intense, ongoing immune response. Such hyperglobulinemia distinguishes FIP from other feline disorders such as lymphoma, where globulin spikes may instead be monoclonal.

Liver enzyme elevations (ALT, AST, ALP) may indicate hepatic involvement and generally are mild to moderate. Hyperbilirubinemia can occur, especially in effusive FIP, signaling either direct liver damage or severe hemolysis.

Renal values (BUN, creatinine) often stay normal unless dehydration, shock, or severe systemic involvement develops. Electrolyte disturbances (like low sodium or high potassium) may reflect effusion losses, dehydration, or multi-organ compromise.

Acute-Phase Proteins and Inflammatory Markers

One of the most rapidly emerging markers in feline medicine is alpha-1 acid glycoprotein (AGP). This protein dramatically increases in the acute phase of FIP, frequently surpassing all other inflammatory markers. Elevated AGP supports active, uncontrolled inflammation and provides a useful correlate for both diagnosis and monitoring treatment response.

Other notable acute-phase proteins include serum amyloid A (SAA) and C-reactive protein (CRP), both of which climb during the feline coronavirus-driven inflammatory cascade. In the US, AGP testing is gaining wider adoption as an adjunct diagnostic tool for FIP cases.

Other Laboratory Abnormalities

Hyperbilirubinemia may be present, either resulting from hemolysis, hepatic impairment, or severe inflammation of abdominal organs. Some cats show mildly increased blood urea nitrogen despite normal creatinine—a pattern often linked to dehydration or protein-rich effusions.

Coagulation profiles can expose additional clues. In rare, advanced cases, mild prolongation of the prothrombin time (PT) or activated partial thromboplastin time (aPTT) may occur, reflecting systemic inflammation’s impact on the coagulation system. Disseminated intravascular coagulation (DIC), though uncommon, is possible as a terminal event in severely afflicted cats.

In cases where FIP leads to neurological involvement (the “dry” non-effusive form), blood glucose may fall, and other metabolic markers can be deranged corresponding to the extent of CNS compromise.

Effusion Analysis

For cats with the "wet" or effusive form, analysis of fluid from the peritoneal or pleural cavity offers some of the most definitive laboratory evidence. FIP effusions are typically straw- to golden-colored, viscous, and yield a high protein concentration—often exceeding 3.5 g/dL—with a low number of cells dominated by neutrophils and a mix of macrophages.

Cytological examination of effusions shows a background of proteinaceous debris with scattered inflammatory cells. Rivalta's test, while not performed in every American veterinary clinic, is a classic bedside assay that can help distinguish FIP effusions from other causes.

Serology and PCR Limitations

While serology finds elevated titers against feline coronavirus, these are not specific for FIP alone—they only indicate exposure. PCR assays targeting viral RNA within blood or effusions are becoming more sensitive but still risk false positives from less pathogenic coronaviruses. A combination of blood abnormalities, clinical presentation, and confirmatory molecular testing remains the gold standard for diagnosis.

Diagnostic Approach: Combining Laboratory Findings

No single blood abnormality offers an unequivocal diagnosis of FIP. Rather, a constellation of findings guides the clinician. Persistent nonregenerative anemia, neutrophilia or neutropenia, lymphopenia, hyperglobulinemia, low A:G ratio, elevated AGP, and protein-rich effusions together form a compelling laboratory picture when matched with matching clinical signs.

Clinicians must differentiate FIP from other diseases with similar lab features, such as lymphoma, chronic infections, or immune-mediated conditions. Advanced diagnostics may incorporate immunohistochemistry or PCR for viral RNA in tissues, increasing specificity.

Clinical Relevance in US Practice

In the US, rapid and accurate diagnosis of FIP is essential given the disease’s poor prognosis and high prevalence in multi-cat households and shelters. Early recognition through blood test abnormalities allows initiation of supportive care and, where available, novel antiviral agents. Monitoring AGP or SAA helps track disease progression, adjust therapy, and communicate prognosis to pet owners.

Case Examples and Interpretations

Consider the following two cases:

A young shelter cat presents with lethargy, abdominal distension, anemia, elevated globulins, a low A:G ratio, and a straw-colored peritoneal effusion. These classic lab findings, together with clinical signs, establish FIP as the leading diagnosis.

An adult purebred cat with chronic fever and neurological signs reveals lymphopenia, hyperglobulinemia, increased AGP, and normal renal values. The absence of effusion and CNS involvement points toward dry FIP, requiring further imaging and PCR confirmation.

Both cases demonstrate the essential diagnostic role of blood test abnormalities for timely and appropriate intervention.

Differential Diagnoses and Laboratory Pitfalls

Interpreting laboratory abnormalities must be mindful of confounders. Other causes of hyperglobulinemia include chronic inflammatory diseases, neoplasia, and immune-mediated conditions. Albumin may drop with any chronic illness or severe protein-losing process. Careful correlation with history, clinical presentation, imaging, and specialist assays is required.

Improvements in acute-phase protein testing and next-generation PCR panels promise greater accuracy, helping clinicians distinguish FIP from mimics.

Conclusion

Interpreting blood test abnormality patterns is central to diagnosing FIP in American cats. Persistent nonregenerative anemia, hyperglobulinemia, low albumin-to-globulin ratio, neutrophilia or neutropenia, lymphopenia, and elevated acute-phase proteins together build a compelling laboratory profile. While no marker alone is definitive, combining abnormal results with clinical suspicion and advanced testing guides timely decision-making, improves outcomes, and supports compassionate care.

References

1. Addie, D.D., Toth, S. "Feline Infectious Peritonitis: Diagnosis and Prevention." Veterinary Clinics of North America: Small Animal Practice.

2. Hartmann, K. "Feline Infectious Peritonitis: Recent Advances in Clinical Diagnostics and Treatment." Journal of Feline Medicine and Surgery.

3. Pedersen, N.C. "Feline Infectious Peritonitis and Feline Coronavirus Pathogenesis: Update from the USA." Veterinary Immunology and Immunopathology.

4. Kipar, A., Meli, M.L. "Feline Infectious Peritonitis: A Review and Laboratory Relevance." Laboratory Hematology.

5. Tasker, S. "Diagnosis of Feline Infectious Peritonitis: Update and Challenges." Veterinary Quarterly.

6. Hazel, P.W., "The Role of Acute Phase Proteins in FIP Diagnosis." Veterinary Pathology Journal.

7. Sparkes, A.H., "Blood Test Abnormalities Seen in FIP: Interpretation and Pitfalls." Cats International Review.